Literature DB >> 3653924

International Conference on Tumor Necrosis Factor and Related Cytotoxins. September 14-18, 1987, Heidelberg, Federal Republic of Germany. Abstracts.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3653924

Source DB:  PubMed          Journal:  Immunobiology        ISSN： 0171-2985            Impact factor:   3.144


× No keyword cloud information.
  8 in total

1.  Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice.

Authors:  Thomas Kamenz; Karel Caca; Thilo Blüthner; Andrea Tannapfel; Joachim Mössner; Marcus Wiedmann
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

2.  Inhibition of histone deacetylase for the treatment of biliary tract cancer: a new effective pharmacological approach.

Authors:  Thilo Bluethner; Manuel Niederhagen; Karel Caca; Frederik Serr; Helmut Witzigmann; Christian Moebius; Joachim Mossner; Marcus Wiedmann
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

3.  Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.

Authors:  Viola Baradari; Michael Höpfner; Alexander Huether; Detlef Schuppan; Hans Scherübl
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

4.  Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.

Authors:  Samuel Wolf; Jana Lorenz; Joachim Mössner; Marcus Wiedmann
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

5.  The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).

Authors:  M Katano; T Mizoguchi; H Yamamoto; M Nakamura; T Matsuo; T Hisatugu; T Kisu; K Yamaoka; O Tokunaga
Journal:  Jpn J Surg       Date:  1990-01

6.  Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.

Authors:  J J Mulé; A Asher; J McIntosh; R Lafreniere; E Shiloni; A Lefor; C M Reichert; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro.

Authors:  Thorsten Lieke; Wolf Ramackers; Sabine Bergmann; Jürgen Klempnauer; Michael Winkler; Johannes Klose
Journal:  BMC Cancer       Date:  2012-10-11       Impact factor: 4.430

8.  Tumor necrosis factor production and colon cancer.

Authors:  H Ito; A Yagita; M Fujitsuka; Y Atomi; I Tatekawa
Journal:  Jpn J Cancer Res       Date:  1996-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.